Skip to content

US Physical Therapy USPH Income Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
$198.29M+7.9%$202.73M+12.3%$197.13M+17.3%$197.34M+18.0%$183.79M+18.1%
$32.75M+5.4%$40.13M+23.4%$36.87M+26.6%$41.62M+22.9%$31.07M+9.4%
16.5%-0.4pp19.8%+1.8pp18.7%+1.4pp21.1%+0.8pp16.9%-1.3pp
$18.27M+12.5%$18.13M+16.4%$17.41M+21.1%$17.48M+22.6%$16.25M+15.3%
$165.53M+8.4%$162.59M+9.9%$160.26M+15.4%$155.72M+16.8%$152.72M+20.0%
$12.48M-36.5%$16.77M-14.7%$25.33M+97.2%$24.94M+60.2%$19.64M+31.6%
6.3%-4.4pp8.3%-2.6pp12.8%+5.2pp12.6%+3.3pp10.7%+1.1pp
-$1.92M+17.1%-$1.81M-36.2%-$2.46M-380%-$2.29M-196%-$2.31M-1,245%
1,056,300,000%-676,500,000%7,781,300,000%+1,760,400,000%2,287,500,000%+1,053,900,000%2,265,300,000%+785,800,000%1,732,800,000%+257,200,000%
$2.41M-37.6%$5.78M-0.8%$5.23M+104%$4.93M+60.0%$3.86M+23.0%
$5.04M-49.1%$4.15M-55.1%$13.14M+98.2%$12.39M+65.1%$9.9M+23.0%
2.5%-2.8pp2%-3.1pp6.7%+2.7pp6.3%+1.8pp5.4%+0.2pp
-$0.12-115%$0.48+23.1%$0.58+23.4%$0.80+73.9%
$18.48M-27.6%$21.4M-15.5%$31.16M+80.8%$31M+54.3%$25.51M+34.1%
9.3%-4.6pp10.6%-3.5pp15.8%+5.6pp15.7%+3.7pp13.9%+1.7pp
$12.48M-36.5%$16.77M-14.7%$25.33M+97.2%$24.94M+60.2%$19.64M+31.6%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What is US Physical Therapy's revenue?
US Physical Therapy (USPH) generated $795.5M in revenue over the trailing twelve months, up 13.7% year over year.
Is US Physical Therapy profitable?
US Physical Therapy reported $34.7M in net income over the trailing twelve months, a 4.4% net margin.
What are US Physical Therapy's profit margins?
Gross margin is 19.0% and operating margin is 10.0%, with a 4.4% net margin.
What is US Physical Therapy's earnings per share?
US Physical Therapy's diluted EPS over the trailing twelve months is $1.74.
Where does US Physical Therapy's income statement data come from?
Every line is extracted from US Physical Therapy's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.